The company, founded in 2009 and based in Cambridge, Massachusetts, has developed a tabletop device that can take a small amount of harvested skin from a patient and expand it by approximately 100 times. This expanded skin can then be grafted onto areas such as scars or other skin-damaged areas, providing a more effective treatment for skin disorders. MoMelan's technology has the potential to revolutionize the field of skin grafting and improve the lives of millions of people around the world.